Puma Biotechnology Stock Market Value
| PBYI Stock | USD 3.39 0.16 4.95% |
| Symbol | Puma |
Puma Biotechnology Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.417 | Earnings Share 0.47 | Revenue Per Share 5.045 | Quarterly Revenue Growth 0.435 | Return On Assets 0.0973 |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Puma Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Puma Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Puma Biotechnology.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Puma Biotechnology on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Puma Biotechnology or generate 0.0% return on investment in Puma Biotechnology over 30 days. Puma Biotechnology is related to or competes with Ultragenyx, Crinetics Pharmaceuticals, Arvinas, Revolution Medicines, Kura Oncology, 2Seventy Bio, and Iovance Biotherapeutics. Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to e... More
Puma Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Puma Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Puma Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.25 | |||
| Information Ratio | 0.0773 | |||
| Maximum Drawdown | 33.65 | |||
| Value At Risk | (4.95) | |||
| Potential Upside | 5.17 |
Puma Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Puma Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Puma Biotechnology's standard deviation. In reality, there are many statistical measures that can use Puma Biotechnology historical prices to predict the future Puma Biotechnology's volatility.| Risk Adjusted Performance | 0.0898 | |||
| Jensen Alpha | 0.2508 | |||
| Total Risk Alpha | (0.20) | |||
| Sortino Ratio | 0.0633 | |||
| Treynor Ratio | 0.2621 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Puma Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Puma Biotechnology Backtested Returns
Puma Biotechnology appears to be unstable, given 3 months investment horizon. Puma Biotechnology maintains Sharpe Ratio (i.e., Efficiency) of 0.15, which implies the firm had a 0.15% return per unit of risk over the last 3 months. By analyzing Puma Biotechnology's technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please evaluate Puma Biotechnology's Risk Adjusted Performance of 0.0898, semi deviation of 4.07, and Coefficient Of Variation of 939.26 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Puma Biotechnology holds a performance score of 11. The company holds a Beta of 1.71, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Puma Biotechnology will likely underperform. Please check Puma Biotechnology's expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Puma Biotechnology's historical price patterns will revert.
Auto-correlation | 0.44 |
Average predictability
Puma Biotechnology has average predictability. Overlapping area represents the amount of predictability between Puma Biotechnology time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Puma Biotechnology price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Puma Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Puma Biotechnology lagged returns against current returns
Autocorrelation, which is Puma Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Puma Biotechnology's stock expected returns. We can calculate the autocorrelation of Puma Biotechnology returns to help us make a trade decision. For example, suppose you find that Puma Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Puma Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Puma Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Puma Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Puma Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Puma Biotechnology Lagged Returns
When evaluating Puma Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Puma Biotechnology stock have on its future price. Puma Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Puma Biotechnology autocorrelation shows the relationship between Puma Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Puma Biotechnology.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Puma Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Puma Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puma Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puma Biotechnology Stock:Check out Puma Biotechnology Correlation, Puma Biotechnology Volatility and Puma Biotechnology Alpha and Beta module to complement your research on Puma Biotechnology. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Puma Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.